搜索





搜索





市场行情
/
股票
/
rvmd
/

Revolution Medicines Inc

RVMD

添加自选

184.000USD

-4.070-2.16%

收盘 07-28 16:00（美东）报价延迟15分钟

36.25B总市值

亏损市盈率 TTM

Revolution Medicines Inc

184.000

-4.070-2.16%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

RVMD 利润表

您可以在这里找到Revolution Medicines Inc的年度或季度收入报告，以深入了解Revolution Medicines Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

营业总收入

----

--0.00

----

-100.00%0.00

--0.00

-100.00%0.00

-95.16%742.00K

-100.00%0.00

-58.05%3.82M

-7.44%7.01M

62.05%15.33M

204.81%3.36M

4.81%9.12M

-25.20%7.58M

8.10%9.46M

-91.30%1.10M

-13.24%8.70M

-12.26%10.13M

-27.61%8.75M

1.24%12.66M

-18.37%10.03M

-12.30%11.55M

16.83%12.09M

--12.51M

--12.28M

--13.17M

--10.35M

营业收入

----

-100.00%0.00

--0.00

-100.00%0.00

-95.16%742.00K

-100.00%0.00

-58.05%3.82M

-7.44%7.01M

62.05%15.33M

204.81%3.36M

4.81%9.12M

-25.20%7.58M

8.10%9.46M

-91.30%1.10M

-13.24%8.70M

-12.26%10.13M

-27.61%8.75M

1.24%12.66M

-18.37%10.03M

-12.30%11.55M

16.83%12.09M

--12.51M

--12.28M

--13.17M

--10.35M

营业费用

84.92%445.22M

67.18%361.63M

79.42%315.27M

68.99%264.71M

70.92%240.76M

19.69%216.31M

42.57%175.71M

39.09%156.64M

71.42%140.86M

134.60%180.72M

54.27%123.25M

58.16%112.62M

25.40%82.17M

23.51%77.04M

47.22%79.89M

33.76%71.20M

37.87%65.53M

45.63%62.37M

34.94%54.26M

40.05%53.23M

45.67%47.53M

35.32%42.83M

54.28%40.21M

66.40%38.01M

38.24%32.63M

43.77%31.65M

--26.07M

--22.84M

--23.60M

--22.02M

研发费用

67.18%343.97M

56.80%294.94M

72.98%262.51M

66.11%224.13M

74.33%205.75M

26.68%188.10M

40.86%151.75M

37.71%134.93M

71.18%118.02M

124.54%148.48M

55.11%107.73M

60.62%97.98M

22.05%68.95M

23.19%66.13M

49.45%69.45M

32.80%61.00M

38.26%56.49M

45.06%53.68M

33.27%46.47M

39.55%45.94M

48.81%40.86M

34.62%37.01M

51.86%34.87M

63.63%32.92M

29.60%27.46M

51.20%27.49M

--22.96M

--20.12M

--21.19M

--18.18M

折旧摊销及损耗

17.77%2.35M

16.31%2.37M

19.98%2.33M

5.97%2.06M

8.26%1.99M

26.01%2.04M

23.93%1.94M

27.51%1.94M

22.26%1.84M

12.07%1.61M

20.54%1.57M

23.72%1.52M

25.31%1.50M

32.81%1.44M

18.18%1.30M

11.91%1.23M

20.10%1.20M

8.50%1.08M

10.00%1.10M

13.64%1.10M

7.30%1.00M

15.61%1.00M

14.55%1.00M

14.69%968.00K

17.53%932.00K

25.18%865.00K

--873.00K

--844.00K

--793.00K

--691.00K

营业利润

-84.92%-445.22M

-67.18%-361.63M

-79.42%-315.27M

-68.99%-264.71M

-70.92%-240.76M

-20.18%-216.31M

-42.57%-175.71M

-43.98%-156.64M

-87.42%-140.86M

-191.67%-179.98M

-61.04%-123.25M

-75.23%-108.80M

-29.70%-75.16M

-16.62%-61.71M

-43.96%-76.53M

-39.42%-62.09M

-54.96%-57.95M

-55.26%-52.91M

-92.96%-53.16M

-59.14%-44.53M

-77.39%-37.40M

-74.20%-34.08M

-103.19%-27.55M

-164.97%-27.98M

-102.01%-21.08M

-67.66%-19.56M

---13.56M

---10.56M

---10.44M

---11.67M

净非营业利息收入（费用）

利息收入

-21.70%19.51M

0.32%21.29M

8.19%22.08M

4.27%22.40M

4.86%24.91M

11.85%21.23M

86.45%20.41M

104.66%21.49M

236.59%23.76M

273.78%18.98M

276.57%10.95M

1110.96%10.50M

2237.42%7.06M

2042.19%5.08M

1203.59%2.91M

267.37%867.00K

29.61%302.00K

-5.95%237.00K

-35.73%223.00K

-67.67%236.00K

-74.37%233.00K

-59.22%252.00K

-54.70%347.00K

55.32%730.00K

171.34%909.00K

70.25%618.00K

--766.00K

--470.00K

--335.00K

--363.00K

利息费用

--12.20M

--11.94M

--11.43M

----

--303.00K

----

--0.00

-100.00%0.00

-42.86%12.00K

-39.13%14.00K

-32.00%17.00K

-32.14%19.00K

-30.00%21.00K

-30.30%23.00K

--25.00K

--28.00K

--30.00K

--33.00K

特殊收入（费用）

-747.31%-15.79M

-5639.55%-12.63M

53.35%-592.00K

-340.06%-4.58M

120.72%2.44M

-291.30%-220.00K

---1.27M

--1.91M

--1.10M

--115.00K

----

--0.00

----

--0.00

其他非经营性收入（费用）

-1070.00%-117.00K

129.41%5.00K

-100.00%0.00

-5718.75%-899.00K

-11.11%-10.00K

---17.00K

--282.00K

--16.00K

---9.00K

----

税前利润

-112.64%-453.82M

-86.82%-364.89M

-95.28%-305.21M

-85.98%-247.79M

-83.97%-213.42M

-21.17%-195.32M

-39.17%-156.29M

-35.54%-133.23M

-70.35%-116.00M

-184.64%-161.19M

-52.53%-112.30M

-60.56%-98.30M

-18.13%-68.10M

-7.51%-56.63M

-39.07%-73.63M

-38.20%-61.22M

-55.07%-57.65M

-55.65%-52.68M

-94.48%-52.94M

-62.43%-44.30M

-84.09%-37.18M

-78.41%-33.84M

-112.37%-27.22M

-169.52%-27.27M

-99.33%-20.19M

-67.29%-18.97M

---12.82M

---10.12M

---10.13M

---11.34M

所得税

----

100.00%0.00

--0.00

----

-319.53%-753.00K

100.00%0.00

--0.00

378.86%343.00K

-1202.02%-3.87M

--0.00

---123.00K

---297.00K

--0.00

-100.00%0.00

--0.00

100.00%0.00

----

108.28%362.00K

--0.00

---58.00K

---675.00K

---4.37M

----

--0.00

----

除税后利润

-112.64%-453.82M

-87.54%-364.89M

-95.28%-305.21M

-85.98%-247.79M

-83.97%-213.42M

-20.45%-194.57M

-44.13%-156.29M

-35.54%-133.23M

-70.35%-116.00M

-185.87%-161.54M

-47.87%-108.43M

-60.56%-98.30M

-18.13%-68.10M

-7.27%-56.51M

-38.51%-73.33M

-38.20%-61.22M

-55.07%-57.65M

-54.01%-52.68M

-94.48%-52.94M

-62.77%-44.30M

-90.46%-37.18M

-134.34%-34.20M

-112.37%-27.22M

-168.95%-27.21M

-92.67%-19.52M

-28.72%-14.60M

---12.82M

---10.12M

---10.13M

---11.34M

持续经营利润

-112.64%-453.82M

-87.54%-364.89M

-95.28%-305.21M

-85.98%-247.79M

-83.97%-213.42M

-20.45%-194.57M

-44.13%-156.29M

-35.54%-133.23M

-70.35%-116.00M

-185.87%-161.54M

-47.87%-108.43M

-60.56%-98.30M

-18.13%-68.10M

-7.27%-56.51M

-38.51%-73.33M

-38.20%-61.22M

-55.07%-57.65M

-54.01%-52.68M

-94.48%-52.94M

-62.77%-44.30M

-90.46%-37.18M

-134.34%-34.20M

-112.37%-27.22M

-168.95%-27.21M

-92.67%-19.52M

-28.72%-14.60M

---12.82M

---10.12M

---10.13M

---11.34M

归属于母公司的净利润

-112.64%-453.82M

-87.54%-364.89M

-95.28%-305.21M

-85.98%-247.79M

-83.97%-213.42M

-20.45%-194.57M

-44.13%-156.29M

-35.54%-133.23M

-70.35%-116.00M

-185.87%-161.54M

-47.87%-108.43M

-60.56%-98.30M

-18.13%-68.10M

-7.27%-56.51M

-38.51%-73.33M

-38.20%-61.22M

-55.07%-57.65M

-54.01%-52.68M

-94.48%-52.94M

-62.77%-44.30M

-71.02%-37.18M

-81.48%-34.20M

-59.51%-27.22M

-106.46%-27.21M

-69.74%-21.74M

-36.00%-18.85M

---17.07M

---13.18M

---12.81M

---13.86M

优先股派息

----

--0.00

----

--0.00

----

-100.00%0.00

-17.08%2.22M

68.76%4.25M

--4.25M

--3.06M

--2.68M

--2.52M

归属于普通股东的净利润

-112.64%-453.82M

-87.54%-364.89M

-95.28%-305.21M

-85.98%-247.79M

-83.97%-213.42M

-20.45%-194.57M

-44.13%-156.29M

-35.54%-133.23M

-70.35%-116.00M

-185.87%-161.54M

-47.87%-108.43M

-60.56%-98.30M

-18.13%-68.10M

-7.27%-56.51M

-38.51%-73.33M

-38.20%-61.22M

-55.07%-57.65M

-54.01%-52.68M

-94.48%-52.94M

-62.77%-44.30M

-71.02%-37.18M

-81.48%-34.20M

-59.51%-27.22M

-106.46%-27.21M

-69.74%-21.74M

-36.00%-18.85M

---17.07M

---13.18M

---12.81M

---13.86M

基本每股收益

-101.96%-2.29

-67.95%-1.88

-72.18%-1.61

-62.86%-1.31

-61.08%-1.13

2.18%-1.12

5.64%-0.94

12.28%-0.81

1.93%-0.70

-80.33%-1.14

-14.65%-0.99

-11.58%-0.92

7.62%-0.72

11.27%-0.63

-20.26%-0.87

-36.56%-0.82

-47.24%-0.78

-38.53%-0.71

-71.62%-0.72

-30.29%-0.60

-43.29%-0.53

-61.25%-0.52

-30.04%-0.42

-107.34%-0.46

-69.74%-0.37

-21.94%-0.32

---0.32

---0.22

---0.26

稀释每股收益

-101.96%-2.29

-67.95%-1.88

-72.18%-1.61

-62.86%-1.31

-61.08%-1.13

2.18%-1.12

5.64%-0.94

12.28%-0.81

1.93%-0.70

-80.33%-1.14

-14.65%-0.99

-11.58%-0.92

7.62%-0.72

11.27%-0.63

-20.26%-0.87

-36.56%-0.82

-47.24%-0.78

-38.53%-0.71

-71.62%-0.72

-30.29%-0.60

-43.29%-0.53

-61.25%-0.52

-30.04%-0.42

-107.34%-0.46

-69.74%-0.37

-21.94%-0.32

---0.32

---0.22

---0.26

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Revolution Medicines Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 RVMD 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Revolution Medicines Inc 全年的净利润是多少？



Revolution Medicines Inc 2025 财年净利润为 -1.13B。

Revolution Medicines Inc 上一季度的净利润是多少？



Revolution Medicines Inc 最近一个季度的净利润为 -453.82M。

Revolution Medicines Inc 年度营业利润是多少？



Revolution Medicines Inc 2025 财年的营业利润为 -1.18B。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。